What is the role of adding aspirin in PIK3CA mutated patients?
What is the role of adding aspirin in PIK3CA mutated patients?
Assoc. Prof. Gerald Prager
The Clinical Question: What is the role of adding aspirin in PIK3CA mutated patients? has been discussed by Assoc. Prof. Gerald Prager and Prof. David Tougeron.
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
| 
5 min
|
2017
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.
Other programmes of interest
28 min
Other programmes developed by Assoc. Prof. Gerald Prager
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
